Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 بازدیدها
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
نظری یافت نشد